For all adverse event suspicion or a security issue of one of our products, please follow the reporting pharmacovigilance procedure indicated below:

Please contact our pharmacovigilance department at :

• Phone : +33 4 78 42 95 26
• Email: pharmacovigilance@stragen.fr

Pharmacovigilance is vital in guarenteeing the safety of medical products. Reportings are essential to ensure a continuous monitoring and in improving the safety of medications. Please feel free to contact our pharmacovigilance team if you have any concerns or questions.